Trademark Overview
On Friday, June 20, 2025, a trademark application was filed for RETRIG with the United States Patent and Trademark Office. The USPTO has given the RETRIG trademark a serial number of 99245347. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 20, 2025. This trademark is owned by SFJ Pharma X, Inc.. The RETRIG trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations